Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

NCT00004189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Lymphoma
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: filgrastim
DRUG: becatecarin
DRUG: cisplatin

Sponsor

National Cancer Institute (NCI)